Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention.
Navarese EP, Kołodziejczak M, Petrescu A, Wernly B, Lichtenauer M, Lauten A, Buffon A, Wanha W, Pestrichella V, Sardella G, Contegiacomo G, Tantry U, Bliden K, Kubica J, Gurbel PA.
Navarese EP, et al. Among authors: tantry u.
Expert Rev Cardiovasc Ther. 2018 Jun;16(6):419-429. doi: 10.1080/14779072.2018.1474099. Epub 2018 May 23.
Expert Rev Cardiovasc Ther. 2018.
PMID: 29737886
Review.